{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:45:51Z","timestamp":1792503951578,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372855"],"award-info":[{"award-number":["82372855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072557"],"award-info":[{"award-number":["82072557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2500900"],"award-info":[{"award-number":["2021YFC2500900"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20XD1402300"],"award-info":[{"award-number":["20XD1402300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022JC023"],"award-info":[{"award-number":["2022JC023"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202240089"],"award-info":[{"award-number":["202240089"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-11141-4","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T06:03:47Z","timestamp":1730181827000},"page":"1594-1604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["CT radiomics to predict pathologic complete response after neoadjuvant immunotherapy plus chemoradiotherapy in locally advanced esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"35","author":[{"given":"Liqiang","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-6033","authenticated-orcid":false,"given":"Hecheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"11141_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"11141_CR2","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","volume":"36","author":"H Yang","year":"2018","unstructured":"Yang H, Liu H, Chen Y et al (2018) Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol 36:2796\u20132803","journal-title":"J Clin Oncol"},{"key":"11141_CR3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","volume":"156","author":"H Yang","year":"2021","unstructured":"Yang H, Liu H, Chen Y et al (2021) Long-term efficacy of neoadjuvant chemoradiotherapy plus surgery for the treatment of locally advanced esophageal squamous cell carcinoma: the NEOCRTEC5010 randomized clinical trial. JAMA Surg 156:721\u2013729","journal-title":"JAMA Surg"},{"key":"11141_CR4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot JJB, Hulshof M et al (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16:1090\u20131098","journal-title":"Lancet Oncol"},{"key":"11141_CR5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamaoncol.2018.5441","volume":"5","author":"MA Shah","year":"2019","unstructured":"Shah MA, Kojima T, Hochhauser D et al (2019) Efficacy and safety of pembrolizumab for heavily pretreated patients with advanced, metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: the phase 2 KEYNOTE-180 study. JAMA Oncol 5:546\u2013550","journal-title":"JAMA Oncol"},{"key":"11141_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1200\/JCO.2017.74.9846","volume":"36","author":"T Doi","year":"2018","unstructured":"Doi T, Piha-Paul SA, Jalal SI et al (2018) Safety and antitumor activity of the anti-programmed death-1 antibody pembrolizumab in patients with advanced esophageal carcinoma. J Clin Oncol 36:61\u201367","journal-title":"J Clin Oncol"},{"key":"11141_CR7","doi-asserted-by":"crossref","unstructured":"Chen X, Xu X, Wang D et al (2023) Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial. J Immunother Cancer 11:e005830","DOI":"10.1136\/jitc-2022-005830"},{"key":"11141_CR8","doi-asserted-by":"crossref","unstructured":"Yang W, Xing X, Yeung SJ et al (2022) Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma. J Immunother Cancer 10:e003497","DOI":"10.1136\/jitc-2021-003497"},{"key":"11141_CR9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejca.2020.11.039","volume":"144","author":"C Li","year":"2021","unstructured":"Li C, Zhao S, Zheng Y et al (2021) Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1). Eur J Cancer 144:232\u2013241","journal-title":"Eur J Cancer"},{"key":"11141_CR10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijrobp.2019.06.079","volume":"105","author":"D Qian","year":"2019","unstructured":"Qian D, Wang Y, Zhao G et al (2019) Tumor remission and tumor-infiltrating lymphocytes during chemoradiation therapy: predictive and prognostic markers in locally advanced esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 105:319\u2013328","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11141_CR11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R et al (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441\u2013446","journal-title":"Eur J Cancer"},{"key":"11141_CR12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103068","volume":"154","author":"M Porcu","year":"2020","unstructured":"Porcu M, Solinas C, Mannelli L et al (2020) Radiomics and \u201cradi-\u2026omics\u201d in cancer immunotherapy: a guide for clinicians. Crit Rev Oncol Hematol 154:103068","journal-title":"Crit Rev Oncol Hematol"},{"key":"11141_CR13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7150\/thno.30309","volume":"9","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wang S, Dong D et al (2019) The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges. Theranostics 9:1303\u20131322","journal-title":"Theranostics"},{"key":"11141_CR14","doi-asserted-by":"crossref","unstructured":"Lu S, Wang C, Liu Y et al (2024) The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma. Eur Radiol 34:485\u2013494","DOI":"10.1007\/s00330-023-10040-4"},{"key":"11141_CR15","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3389\/fonc.2020.01398","volume":"10","author":"Q Qiu","year":"2020","unstructured":"Qiu Q, Duan J, Deng H et al (2020) Development and validation of a radiomics nomogram model for predicting postoperative recurrence in patients with esophageal squamous cell cancer who achieved pCR after neoadjuvant chemoradiotherapy followed by surgery. Front Oncol 10:1398","journal-title":"Front Oncol"},{"key":"11141_CR16","volume":"94","author":"C Zhang","year":"2021","unstructured":"Zhang C, Shi Z, Kalendralis P et al (2021) Prediction of lymph node metastases using pre-treatment PET radiomics of the primary tumour in esophageal adenocarcinoma: an external validation study. Br J Radiol 94:20201042","journal-title":"Br J Radiol"},{"key":"11141_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.xjon.2021.11.003","volume":"9","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Li C, Yu B et al (2022) Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: trial design. JTCVS Open 9:293\u2013299","journal-title":"JTCVS Open"},{"key":"11141_CR18","doi-asserted-by":"crossref","first-page":"e2015927","DOI":"10.1001\/jamanetworkopen.2020.15927","volume":"3","author":"Y Hu","year":"2020","unstructured":"Hu Y, Xie C, Yang H et al (2020) Assessment of intratumoral and peritumoral computed tomography radiomics for predicting pathological complete response to neoadjuvant chemoradiation in patients with esophageal squamous cell carcinoma. JAMA Netw Open 3:e2015927","journal-title":"JAMA Netw Open"},{"key":"11141_CR19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00330-023-10040-4","volume":"34","author":"S Lu","year":"2024","unstructured":"Lu S, Wang C, Liu Y et al (2024) The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma. Eur Radiol 34:485\u2013494","journal-title":"Eur Radiol"},{"key":"11141_CR20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49:1373\u20131379","journal-title":"J Clin Epidemiol"},{"key":"11141_CR21","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-023-02323-z","volume":"23","author":"N Sancar","year":"2023","unstructured":"Sancar N, Tabrizi SS (2023) Machine learning approach for the detection of vitamin D level: a comparative study. BMC Med Inform Decis Mak 23:219","journal-title":"BMC Med Inform Decis Mak"},{"key":"11141_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13321-019-0343-x","volume":"11","author":"W Hemati","year":"2019","unstructured":"Hemati W, Mehler A (2019) CRFVoter: gene and protein related object recognition using a conglomerate of CRF-based tools. J Cheminform 11:21","journal-title":"J Cheminform"},{"key":"11141_CR23","volume":"17","author":"Y Cui","year":"2022","unstructured":"Cui Y, Li Z, Xiang M, Han D, Yin Y, Ma C (2022) Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures. Radiat Oncol 17:212","journal-title":"Radiat Oncol"},{"key":"11141_CR24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster B, Wynants L, Verbeek JFM et al (2018) Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol 74:796\u2013804","journal-title":"Eur Urol"},{"key":"11141_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2023.02.009","volume":"91","author":"J Li","year":"2023","unstructured":"Li J, Li L, You P, Wei Y, Xu B (2023) Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer. Semin Cancer Biol 91:35\u201349","journal-title":"Semin Cancer Biol"},{"key":"11141_CR26","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu L, Wei XF, Li CJ et al (2022) Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. Front Immunol 13:1052542","journal-title":"Front Immunol"},{"key":"11141_CR27","volume":"13","author":"ZN Hong","year":"2022","unstructured":"Hong ZN, Gao L, Weng K, Huang Z, Han W, Kang M (2022) Safety and feasibility of esophagectomy following combined immunotherapy and chemotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score matching analysis. Front Immunol 13:836338","journal-title":"Front Immunol"},{"key":"11141_CR28","doi-asserted-by":"crossref","first-page":"e185896","DOI":"10.1001\/jamaoncol.2018.5896","volume":"5","author":"JJ Smith","year":"2019","unstructured":"Smith JJ, Strombom P, Chow OS et al (2019) Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol 5:e185896","journal-title":"JAMA Oncol"},{"key":"11141_CR29","volume":"16","author":"T Yan","year":"2022","unstructured":"Yan T, Liu L, Yan Z et al (2022) A radiomics nomogram for non-invasive prediction of progression-free survival in esophageal squamous cell carcinoma. Front Comput Neurosci 16:885091","journal-title":"Front Comput Neurosci"},{"key":"11141_CR30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT (2018) Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 15:81\u201394","journal-title":"Nat Rev Clin Oncol"},{"key":"11141_CR31","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2017.12.268","volume":"102","author":"GJR Cook","year":"2018","unstructured":"Cook GJR, Azad G, Owczarczyk K, Siddique M, Goh V (2018) Challenges and promises of PET radiomics. Int J Radiat Oncol Biol Phys 102:1083\u20131089","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11141_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2021.106609","volume":"215","author":"A Abbasian Ardakani","year":"2022","unstructured":"Abbasian Ardakani A, Bureau NJ, Ciaccio EJ, Acharya UR (2022) Interpretation of radiomics features\u2014a pictorial review. Comput Methods Programs Biomed 215:106609","journal-title":"Comput Methods Programs Biomed"},{"key":"11141_CR33","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2589-7500(21)00215-6","volume":"4","author":"L Feng","year":"2022","unstructured":"Feng L, Liu Z, Li C et al (2022) Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health 4:e8\u2013e17","journal-title":"Lancet Digit Health"},{"key":"11141_CR34","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi Z, Huang X, Cheng Z et al (2023) MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer. Radiology 308:e222830","journal-title":"Radiology"},{"key":"11141_CR35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1148\/rg.2017170056","volume":"37","author":"MG Lubner","year":"2017","unstructured":"Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ (2017) CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics 37:1483\u20131503","journal-title":"Radiographics"},{"key":"11141_CR36","volume":"21","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Yao W, Xu BC et al (2021) Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive radiomic biomarkers. BMC Cancer 21:1167","journal-title":"BMC Cancer"},{"key":"11141_CR37","volume":"14","author":"SJ Cho","year":"2024","unstructured":"Cho SJ, Cho W, Choi D et al (2024) Prediction of treatment response after stereotactic radiosurgery of brain metastasis using deep learning and radiomics on longitudinal MRI data. Sci Rep 14:11085","journal-title":"Sci Rep"},{"key":"11141_CR38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1109\/JBHI.2020.3002805","volume":"25","author":"L Meng","year":"2021","unstructured":"Meng L, Dong D, Chen X et al (2021) 2D and 3D CT radiomic features performance comparison in characterization of gastric cancer: a multi-center study. IEEE J Biomed Health Inform 25:755\u2013763","journal-title":"IEEE J Biomed Health Inform"},{"key":"11141_CR39","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s11547-023-01676-9","volume":"128","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang G, Qiu X et al (2023) Radiomics under 2D regions, 3D regions, and peritumoral regions reveal tumor heterogeneity in non-small cell lung cancer: a multicenter study. Radiol Med 128:1079\u20131092","journal-title":"Radiol Med"},{"key":"11141_CR40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.media.2009.12.005","volume":"14","author":"A Oliver","year":"2010","unstructured":"Oliver A, Freixenet J, Marti J et al (2010) A review of automatic mass detection and segmentation in mammographic images. Med Image Anal 14:87\u2013110","journal-title":"Med Image Anal"},{"key":"11141_CR41","doi-asserted-by":"crossref","unstructured":"Abdoli N, Zhang K, Gilley P et al (2023) Evaluating the effectiveness of 2D and 3D CT image features for predicting tumor response to chemotherapy. Bioengineering 10:1334","DOI":"10.3390\/bioengineering10111334"},{"key":"11141_CR42","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1002\/mp.14538","volume":"47","author":"D Arefan","year":"2020","unstructured":"Arefan D, Chai R, Sun M, Zuley ML, Wu S (2020) Machine learning prediction of axillary lymph node metastasis in breast cancer: 2D versus 3D radiomic features. Med Phys 47:6334\u20136342","journal-title":"Med Phys"},{"key":"11141_CR43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00261-023-04070-1","volume":"49","author":"Y Li","year":"2024","unstructured":"Li Y, Yang L, Gu X et al (2024) Computed tomography radiomics identification of T1-2 and T3-4 stages of esophageal squamous cell carcinoma: two-dimensional or three-dimensional? Abdom Radiol (NY) 49:288\u2013300","journal-title":"Abdom Radiol (NY)"},{"key":"11141_CR44","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1007\/s00261-020-02820-z","volume":"46","author":"S Nougaret","year":"2021","unstructured":"Nougaret S, McCague C, Tibermacine H, Vargas HA, Rizzo S, Sala E (2021) Radiomics and radiogenomics in ovarian cancer: a literature review. Abdom Radiol (NY) 46:2308\u20132322","journal-title":"Abdom Radiol (NY)"},{"key":"11141_CR45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.diii.2018.11.007","volume":"100","author":"S Nougaret","year":"2019","unstructured":"Nougaret S, Tardieu M, Vargas HA et al (2019) Ovarian cancer: an update on imaging in the era of radiomics. Diagn Interv Imaging 100:647\u2013655","journal-title":"Diagn Interv Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-11141-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T13:37:03Z","timestamp":1739885823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-11141-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["11141"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-11141-4","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"10 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is H.L.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all patients in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by our hospital\u2019s institutional review board (2020-109, ClinicalTrials.gov number, NCT03792347, NCT04435197).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}